Fishman Corey N. 4
4 · Iterum Therapeutics plc · Filed Mar 15, 2022
Insider Transaction Report
Form 4
Fishman Corey N.
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Ordinary Shares
2022-03-11+215,000→ 537,008 total - Exercise/Conversion
Restricted Share Units
2022-03-11−215,000→ 215,000 total→ Ordinary Shares (215,000 underlying)
Footnotes (2)
- [F1]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F2]On March 11, 2021, the reporting person was granted an award of 430,000 RSUs, 50% of which vested on March 11, 2022.